Seattle, WA, United States of America

Leland Harrison Hartwell

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Earli Inc.. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leland Harrison Hartwell. Retrieved from https://idiyas.com/inventor/leland-harrison-hartwell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Leland Harrison Hartwell: Innovator in Synthetic Biomarkers

Introduction

Leland Harrison Hartwell is a prominent inventor based in Seattle, WA. He has made significant contributions to the field of synthetic biomarkers, holding two patents that showcase his innovative work. His research focuses on the detection of diseased cells through advanced genetic elements.

Latest Patents

Hartwell's latest patents include methods and compositions for synthetic biomarkers. The present disclosure encompasses embodiments of nucleic acids comprising genetic elements which are useful for the detection of diseased cells. This groundbreaking work has the potential to enhance diagnostic capabilities in medical science.

Career Highlights

Throughout his career, Hartwell has been associated with Earli Inc., where he continues to push the boundaries of innovation in biotechnology. His expertise in synthetic biomarkers has positioned him as a key figure in the industry.

Collaborations

Some of Hartwell's notable coworkers include David Suhy and Paul Escarpe. Their collaborative efforts contribute to the advancement of research and development in their field.

Conclusion

Leland Harrison Hartwell's work in synthetic biomarkers exemplifies the impact of innovation in healthcare. His patents and ongoing research are paving the way for improved detection methods, ultimately benefiting patients and the medical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…